Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 25, 2023 16:05 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro to Announce Second Quarter 2023 Results August 8, 2023

SOLANA BEACH, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
May 25, 2023 08:51 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro en UCB gaan licentieovereenkomst aan voor toediening van gentherapiegeneesmiddelen

SOLANA BEACH, Californië, May 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT), een multinational die platforms ontwikkelt voor therapie met navigatie naar en levering aan de...
May 25, 2023 08:51 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro y UCB firman un acuerdo de licencia para la administración de fármacos de terapia génica

SOLANA BEACH, California, May 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT), una empresa global de plataformas habilitadoras de terapias que ofrecen navegación y administración...
May 25, 2023 08:51 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro e UCB stipulano un contratto di licenza per la somministrazione di farmaci per la terapia genetica

SOLANA BEACH, California, May 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT), società globale di piattaforme terapeutiche che fornisce navigazione e somministrazione al cervello,...
May 25, 2023 08:51 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro und UCB unterzeichnen Lizenzvereinbarung für die Verabreichung von Gentherapeutika

SOLANA BEACH, Kalifornien, May 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT), ein weltweit tätiges Unternehmen, das Neuronavigationssysteme für die Durchführung von Eingriffen...
May 25, 2023 08:51 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro et UCB concluent un accord de licence pour l'administration de médicaments de thérapie génique

SOLANA BEACH, Californie, 25 mai 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ : CLPT), une société mondiale de plateformes thérapeutiques permettant la navigation et l'administration vers...
May 24, 2023 09:25 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

SOLANA BEACH, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) a global therapy-enabling platform company providing navigation and delivery to the brain, today...
May 18, 2023 16:01 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference

SOLANA BEACH, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
May 11, 2023 16:05 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro Reports First Quarter 2023 Results

SOLANA BEACH, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
May 10, 2023 16:05 ET | Source: ClearPoint Neuro, Inc.

ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles

SOLANA BEACH, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...